Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Point72 Asset Management, L.P. reported a 5.50% stake in Kalvista Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jan 5, 2026 · Filed Jan 13, 2026
Point72 Asset Management, L.P. reported a 5.50% stake in Kalvista Pharmaceuticals, Inc., 2,781,902 shares, as a passive investor on Jan 5, 2026. Filed Jan 13, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 2,781,902
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.50% | 2,781,902 |
| Point72 Capital Advisors, Inc. | 5.50% | 2,781,902 |
| Steven A. Cohen | 5.50% | 2,781,902 |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Kalvista Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jan 12, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026